Hyperhidrosis: the impact of therapeutic options on patients’ quality of life
Article Sidebar
Main Article Content
Abstract
Objective: To analyze the impact of therapeutic options on the quality of life of patients with hyperhidrosis. Methods: This is an integrative review, in which a search for previous work was carried out on the PubMed and Lilacs platforms and a total of 23 scientific articles were included after applying inclusion and exclusion criteria. Results: Through the analyzed studies, it was observed that the main limitations of hyperhidrotic drugs were related to the social part and the more conservative treatments showed better outcomes in mild or moderate cases, while more invasive approaches were better indicated in severe cases. The social scope was greatly affected by the condition, the patients had difficulties in being in environments with interaction, touching other people, dealing with body odor and handling objects. Finally, the therapeutic options played a great role in controlling sweating, thus demonstrating a favorable outcome in terms of improved quality of life. Final considerations: It is important that there is greater dissemination of information in our society about the disease and available treatments, as well as better screening of the condition so that individuals can be diagnosed early.
Article Details
Copyright © | All rights reserved.
The journal holds the exclusive copyright for the publication of this article under the terms of Brazilian law 9610/98.
Partial reproduction
The use of parts of the texts, figures and questionnaire of the article is free, being mandatory the citation of the authors and journal.
Total reproduction
It is expressly prohibited and must be authorized by the journal.
References
2. BASTO AC, et al. Impacto da hiperidrose nas atividades laborais da enfermagem em um hospital de urgência e emergência. Rev. Pesqui, 2020;12(1):1283-1289.
3. BERGÓN-SENDÍN M, et al. Preliminary Experience with Transdermal Oxybutynin Patches for Hyperhidrosis. Actas Dermosifiliogr, 2016;107(10):845-850.
4. CAMPOS JJG, et al. Impact of primary hyperhidrosis on the life of physical education academics of a university in the Brazilian Northeast. Motriz. Rev. Educ. Fis., 2019;25(2).
5. GRABELL DA, HEBERT AA. Current and Emerging Medical Therapies for Primary Hyperhidrosis. Dermatol Ther (Heidelb), 2017; 7(1):25-36.
6. GROSS KM, et al. Elevated social stress levels and depressive symptoms in primary hyperhidrosis. PLoS One, 2014;9(3).
7. HASIMOTO EN, et al. Hyperhidrosis: prevalence and impact on quality of life. J Bras Pneumol, 2018; 44(4):292-298.
8. KAMUDONI P, et al. The development and validation of a disease-specific quality of life measure in hyperhidrosis: the Hyperhidrosis Quality of Life Index (HidroQOL©). Qual Life Res, 2015;24(4):1017-27.
9. KAMUDONI P, et al. The impact of hyperhidrosis on patients' daily life and quality of life: a qualitative investigation. Health Qual Life Outcome, 2017;15(1):121.
10. LEÃO LE, et al. Role of video-assisted thoracoscopic sympathectomy in the treatment of primary hyperhidrosis. Sao Paulo Med J, 2003;121(5):191-7.
11. LEE HH, et al. Efficacy of glycopyrrolate in primary hyperhidrosis patients. Korean J Pain, 2012;25(1):28-32.
12. LEIDERMAN DBD, et al. The relation between age and outcomes of thoracic sympathectomy for hyperhidrosis: The older the better. J Thorac Cardiovasc Surg, 2018;156(4):1748-1756.
13. LENEFSKY M, RICE ZP. Hyperhidrosis and its impact on those living with it. Am J Manag Care, 2018;24(23):491-495.
14. LI DC, et al. Endoscopic thoracic sympathectomy for primary focal hyperhidrosis: impact on psycho-social symptomatology and psychotropic medication use. Eur J Cardiothorac Surg, 2018;54(5):904-911.
15. LIMA SO, et al. Perfil Epidemiológico e Qualidade de Vida dos Estudantes de Medicina Portadores de Hiperidrose Primária. Revista Brasileira de Educação Médica, 2020;43(1):386-394.
16. MCCONAGHY JR, FOSSELMAN D. Hyperhidrosis: Management Options. Am Fam Physician, 2018;97(11):729-734.
17. MEHMET AK, et al. Temperament and character properties of primary focal hyperhidrosis patients. Health Qual Life Out-comes, 2013; 11(5).
18. MUTHUSAMY A, et al. A Study on the Impact of Hyperhidrosis on the Quality of Life among College Students. J Clin Diagn Res, 2016; 10(6)
19. PARISER DM, et al. Topical Glycopyrronium Tosylate for the Treatment of Primary Axillary Hyperhidrosis: Patient-Reported Outcomes from the AT-MOS-1 and ATMOS-2 Phase III Randomized Controlled Trials. Am J Clin Dermatol, 2019;20(1):135-145.
20. PARK HS, et al. Thoracic sympathetic nerve reconstruction for compensatory hyper-hidrosis: the Melbourne technique. Ann Transl Med, 2014;2(5):45.
21. RIBEIRO MMS, et al. Primary hyperhidrosis prevalence and characteristics among medical students in Rio de Janeiro. PLoS One, 2014; 14(9).
22. ROMERO FR, et al. Palmar hyperhidrosis: clinical, pathophysiological, diagnostic and therapeutic aspects. An Bras Dermatol, 2016;91(6):716-725.
23. ROSELL K, et al. Botulinum toxin type A and B improve quality of life in patients with axillary and palmar hyperhidrosis. Acta Derm Venereol, 2013;93(3):335-9.
24. SANCLEMENTE G, et al. The impact of skin diseases on quality of life: A multicenter study. Actas Dermosifiliogr, 2017;108(3):244-252.
25. WOLOSKER N, et al. Long-term results of oxybutynin use in treating facial hyperhidrosis. An Bras Dermatol, 2014;89(6):912-6.
26. WOOLERY-LLOYD H, VALINS W. Aluminum chloride hexahydrate in a salicylic Acid gel: a novel topical agent for hyperhidrosis with decreased irritation. J Clin Aesthet Dermatol, 2009;2(6):28-31.
27. YOUNG O, et al. Evaluation of the impact of transthoracic endoscopic sympathectomy on patients with palmar hyperhydrosis. Eur J Vasc Endovasc Surg, 2003;26(6):673-6.